CTI BIOPHARMA CORP - COM (CTIC)

CUSIP: 12648L106

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / COM
Total 13F shares
71,231,182
Share change
-10,117,000
Total reported value
$26,658,875
Price per share
$0.37
Number of holders
53
Value change
-$3,705,910
Number of buys
16
Number of sells
31

Quarterly Holders Quick Answers

What is CUSIP 12648L106?
CUSIP 12648L106 identifies CTIC - CTI BIOPHARMA CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CTI BIOPHARMA CORP - COM (CTIC) as of Q3 2016

As of 30 Sep 2016, CTI BIOPHARMA CORP - COM (CTIC) was held by 53 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 71,231,182 shares. The largest 10 holders included BVF INC/IL, VANGUARD GROUP INC, FMR LLC, BlackRock Institutional Trust Company, N.A., RENAISSANCE TECHNOLOGIES LLC, GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, MILLENNIUM MANAGEMENT LLC, and DEUTSCHE BANK AG\. This page lists 53 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.